...
【24h】

Allergic fungal rhinosinusitis

机译:过敏性真菌鼻鼻窦炎

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

INSTRUCTIONS: Credit can now be obtained, free for a limited time, by reading the review article in this issue and completing all activity components. Please note the instructions listed below: Review the target audience, learning objectives and all disclosures. Complete the pre-test online at http://www.annallergy.org (click on the CME heading). Follow the online instructions to read the full version of the article, including the clinical vignette; reflect on all content as to how it may be applicable to your practice. Complete the post-test/evaluation and claim credit earned; at this time, you will have earned up to 1.0 AMA PRA Category 1 Credit?. Please note that the minimum passing score on the post-test is 70%. Approximately 4-6 weeks later you will receive an online assessment regarding your application of this article to your practice. Once you have completed this assessment, you will be eligible to receive MOC Part II credit from the American Board of Allergy and Immunology. Release Date: April 1, 2013. Expiration Date: March 31, 2015. Estimated Time to Complete: 60 minutes. Target Audience: Physicians involved in providing patient care in the field of allergy/asthma/immunology. Learning Objectives:At the conclusion of this activity, participants should be able to: Describe the pathophysiology and presenting features of patients with allergic fungal rhinosinusitis. Discuss the best management approaches to patients with allergic fungal rhinosinusitis Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit?. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Planning Committee Members: Fuad M. Baroody, MD (Author) Michael S. Tankersley, MD (CME Series Editor) Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief) Disclosure of Relevant Financial Relationships: M.P. Silva, EM. Baroody, M.S. Tankersley, and G.D. Marshall have no relevant financial relationships to disclose. Reviewers and Education/ Editorial staff have no relevant financial relationships to disclose. No experimental/investigative use of a product/device is discussed. Recognition of Commercial Support: This activity has not received external commercial support. Copyright Statement: ? 2013-2015 ACAAI. All rights reserved. CME Inquiries: Contact the American College of Allergy, Asthma & Immunology at education@acaai.org or 847-427-1200.
机译:说明:现在,可以通过阅读本期的评论文章并完成所有活动组成部分,在有限的时间内免费获得积分。请注意以下说明:复习目标受众,学习目标和所有披露事项。通过http://www.annallergy.org在线完成预测试(单击CME标题)。按照在线说明阅读文章的完整版本,包括临床插图;反思所有内容,以了解它们如何适用于您的实践。完成测试后/评估并获得所获得的抵免额;目前,您将获得最多1.0 AMA PRA 1类信用?。请注意,后测的最低及格分数是70%。大约4-6周后,您将收到有关本文在实践中的应用的在线评估。完成评估后,您将有资格从美国过敏和免疫学委员会获得MOC第II部分信用。发行日期:2013年4月1日。到期日期:2015年3月31日。预计完成时间:60分钟。目标受众:在过敏/哮喘/免疫学领域为患者提供护理的医师。学习目标:在此活动结束时,参与者应该能够:描述过敏性真菌性鼻鼻窦炎患者的病理生理和表现特点。讨论对过敏性真菌鼻-鼻窦炎患者的最佳管理方法认证:美国过敏,哮喘和免疫学学院(ACAAI)已获得持续医学教育认证委员会(ACCME)的认可,为医师提供持续医学教育。名称:美国过敏,哮喘和免疫学学院(ACAAI)将这种基于期刊的CME活动指定为最多1项AMA PRA 1类信用?。医师应仅索取与其参与活动的程度相称的积分。计划委员会成员:医学博士Fuad M.Baroody(作者)医学博士Michael S.Tankersley(CME系列编辑)医学博士Gailen D.Marshall,医学博士(总编)相关财务关系的披露:医学硕士EM,席尔瓦。 M.S. Baroody Tankersley和G.D. Marshall没有要披露的相关财务关系。审稿人和教育/编辑人员没有相关的财务关系要披露。没有讨论产品/设备的实验/研究用途。认可商业支持:此活动尚未获得外部商业支持。版权声明: 2013-2015 ACAAI。版权所有。芝商所查询:联系美国过敏,哮喘和免疫学学院,电子邮件:education@acaai.org或847-427-1200。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号